Special Issue

Cardiopulmonary Exercise Testing for Patients with Heart Disease

Submission Deadline: 31 Jan 2025

Guest Editors

Special Issue Information

Dear Colleagues,

We are excited to announce a special issue of Reviews in Cardiovascular Medicine dedicated to the critical and evolving role of Cardiopulmonary Exercise Testing (CPET) for patients with heart disease. This issue aims to highlight the significance of CPET in assessing cardiovascular health and guiding therapeutic strategies. We invite authors and scientists to contribute their research and insights, exploring various aspects of CPET and its application in the management of heart conditions.

The special issue will delve into the utilization of CPET as a powerful diagnostic tool, shedding light on its role in evaluating cardiac and pulmonary function during exercise stress testing. Authors are encouraged to delve into topics encompassing heart failure, different cardiomyopathies (i.e. Hypertrophic Cardiomyopathy, Cardiac Amyloidosis), and emerging therapies, elucidating how CPET can aid in the prognosis and treatment of these conditions.

By fostering a collection of diverse and cutting-edge research articles, this special issue endeavors to advance our understanding of CPET and its potential to revolutionize cardiovascular care. We look forward to a collaborative effort from the research community, presenting a comprehensive view of the advancements in CPET and its implications for the future of cardiac healthcare.

Dr. Massimo Mapelli and Dr. Elisabetta Salvioni
Guest Editors

Keywords

  • heart failure
  • exercise
  • cardiopulmonary exercise testing
  • CPET
  • cardiomyopathies
  • cardiovascular therapy
  • hypertrophic cardiomyopaty
  • cardiac amyloidosis
  • heart failure prognosis

Manuscript Submission Information

Manuscripts should be submitted via our online editorial system at https://imr.propub.com by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website. 

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted manuscripts should be well formatted in good English.

Published Papers (4)

Open Access Original Research

Potential Hematopoietic Effects of SGLT2 Inhibitors in Patients with Cardiac Amyloidosis

Nikita Ermolaev, Robin Willixhofer, Christoph Krall, Christina Kronberger, René Rettl, Christina Binder, Franz Duca, Christian Nitsche, Andreas Kammerlander, Michael Poledniczek, Bernhard Gregshammer, Diana Ahmadi-Fazel, Mahshid Eslami, Luciana Camuz Ligios, Johannes Kastner, Jutta Bergler-Klein, Roza Badr Eslam

Rev. Cardiovasc. Med. 2025, 26(3), 26081; https://doi.org/10.31083/RCM26081

(This article belongs to the Special Issue Cardiopulmonary Exercise Testing for Patients with Heart Disease)

410
104
1
Open Access Review
383
131
1